BIANUCCI, ANNA MARIA PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 10.979
AS - Asia 6.126
EU - Europa 4.569
SA - Sud America 639
AF - Africa 342
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 22.679
Nazione #
US - Stati Uniti d'America 10.628
CN - Cina 1.906
SG - Singapore 1.899
IT - Italia 1.181
SE - Svezia 732
HK - Hong Kong 727
BR - Brasile 542
VN - Vietnam 537
DE - Germania 530
BG - Bulgaria 384
TR - Turchia 321
UA - Ucraina 315
CA - Canada 289
FR - Francia 288
GB - Regno Unito 287
KR - Corea 278
FI - Finlandia 241
CH - Svizzera 166
RU - Federazione Russa 165
JP - Giappone 121
IN - India 115
AT - Austria 113
NG - Nigeria 110
CI - Costa d'Avorio 78
SN - Senegal 63
BE - Belgio 48
BD - Bangladesh 47
AR - Argentina 32
IQ - Iraq 29
MX - Messico 28
PL - Polonia 25
ES - Italia 22
ID - Indonesia 22
NL - Olanda 22
ZA - Sudafrica 22
EG - Egitto 18
PK - Pakistan 15
CO - Colombia 14
UZ - Uzbekistan 14
LT - Lituania 13
SA - Arabia Saudita 12
VE - Venezuela 12
AU - Australia 11
EC - Ecuador 11
KE - Kenya 11
CL - Cile 10
DZ - Algeria 9
PH - Filippine 9
CZ - Repubblica Ceca 8
IR - Iran 8
MO - Macao, regione amministrativa speciale della Cina 8
MA - Marocco 7
AZ - Azerbaigian 6
HN - Honduras 6
JM - Giamaica 6
OM - Oman 6
PE - Perù 6
PY - Paraguay 6
TN - Tunisia 6
BB - Barbados 5
EU - Europa 5
GR - Grecia 5
JO - Giordania 5
KG - Kirghizistan 5
MY - Malesia 5
BJ - Benin 4
BO - Bolivia 4
ET - Etiopia 4
IE - Irlanda 4
IL - Israele 4
KZ - Kazakistan 4
NP - Nepal 4
PA - Panama 4
AL - Albania 3
AO - Angola 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
BS - Bahamas 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
MN - Mongolia 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
FJ - Figi 1
Totale 22.660
Città #
Singapore 1.084
Ashburn 1.073
Ann Arbor 1.067
Woodbridge 931
Chandler 921
Hong Kong 712
Santa Clara 663
Dallas 580
Houston 578
San Jose 571
Milan 468
Fairfield 462
Jacksonville 446
Beijing 427
Sofia 384
Hefei 373
Shanghai 283
Seoul 275
Ottawa 251
New York 238
Izmir 213
Wilmington 204
Seattle 191
Princeton 189
Nanjing 165
Bern 160
Boardman 153
Cambridge 152
Lawrence 145
Lauterbourg 131
Los Angeles 129
Ho Chi Minh City 124
Tokyo 116
Lagos 110
Hanoi 109
Medford 108
Vienna 105
Dearborn 97
Des Moines 93
Florence 93
Serra 81
Jüchen 80
Istanbul 79
Abidjan 78
Munich 73
Dong Ket 69
Buffalo 68
Lancaster 67
Dakar 63
Marseille 61
Nanchang 57
Helsinki 52
Brussels 48
London 47
Boulder 45
Orem 43
Frankfurt am Main 42
Redondo Beach 41
São Paulo 41
Kunming 40
Ogden 40
Shenyang 40
The Dalles 40
Pune 36
Atlanta 35
Columbus 35
Council Bluffs 35
Bremen 34
Rome 34
Düsseldorf 32
Tianjin 28
Chicago 27
Da Nang 27
Changsha 25
Hebei 25
Brasília 21
Falls Church 21
San Diego 21
Warsaw 21
Nürnberg 20
San Francisco 19
Toronto 19
Turku 19
Chennai 18
Fuzhou 18
Jiaxing 18
Dhaka 16
Hangzhou 16
Norwalk 16
Redwood City 16
Brooklyn 15
Falkenstein 15
Amsterdam 14
Belo Horizonte 14
Denver 14
Haiphong 14
Orange 14
Auburn Hills 13
Guangzhou 13
Phoenix 13
Totale 16.660
Nome #
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 290
Cell-specific pattern of berberine pleiotropic effects on different human cell lines 249
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 246
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 244
N-(9-Benzyl-2-phenyl-9H-8azapurin-6-yl)-amides: A new class of A1 adenosine receptor ligands 242
The in vivo effect of chelidonine on the stem cell system of planarians 238
The regenerative biology of the planarian model for evaluating the effects of isoquinoline alkaloids: a case study with berberine 238
A cellular and molecular study of the effects of chelidonine and berberine alkaloids on planarian regeneration 229
Design of fibrin-specific ligands for drug targeting 227
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 227
Development of Classification Model batteries for predicting inhibition of tubulin polymerization by small molecules 224
N-[9-(ortho-Fluorobenzyl)-2-Phenyl-8-Azapurin-6-yl]-Amides as Potent and Selective Ligands for A1 Adenosine Receptors. 219
Novel 8-azapurine derivatives as ligands for A3 adenosine receptors 212
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 212
2-Fenyl-9-benzyl-6-arylamido-8-azapurines: new potent ligands of adenosine receptors 211
Binding free energy calculations of Adenosine Deaminase inhibitors 209
Aiming to understand the mechanisms underlying the different responses to berberine among different cell lines 208
A CONFORMATIONAL APPROACH TO HISTAMINE H-2-RECEPTOR ANTAGONISTS 199
A QSAR study of A1adenosine receptor antagonists by a new neural network model 199
Molecular Modeling of CYP2D6 complexes and docking of a series of ajmalicine- and quinidine-like inhibitors 199
Optimizing QSAR Models for Predicting Ligand Binding to the Drug-Metabolizing Cytochrome P450 Isoenzyme CYP2D6 195
Benzodiazepine Receptor Ligands and Lactate-Dehydrogenase interactions 191
Binding mode of Adenosine Deaminase inhibitors and zinc modeling 191
Astacin gene family of metalloproteinases in planarians: Structural organization and tissue distribution 191
2,9-Disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: Synthesis, biochemical and molecular modelling studies 190
Development of Classification Models for Identifying “True” P-glycoprotein (P-gp) Inhibitors Through Inhibition, ATPase Activation and Monolayer Efflux Assays 190
Nanoparticles for smart drug delivery system: computational approach for the design of fibrinolytic drugs 189
Design, synthesis and biological characterization of bivalent theophylline derivatives at adenosina A1 receptors 188
In vitro studies of wound healing properties of Chelidonium majus flowers extracts 187
QSAR models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the hERG potassium channel inhibition 185
Solution Structure of [d(GGTATACC)]2: Wrinkled D Structure of the TATA Moiety 184
Design, Synthesis and Biological Characterization of Bivalent Ligands as Modulators of Adenosine A1 Receptors 184
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 184
Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase 184
STERIC REQUIREMENT OF A METHYL-GROUP IN SIMPLE-MODELS OF ANHYDROPYRANOSES 183
Analysis of the Internal Representations Developed By Neural Networks for Structures Applied to Quantitative Structure-Activity Relationship Studies of Benzodiazepines 183
QSAR models for predicting enzymatic hydrolysis of new chemical entities in 'soft-drug' design 181
Synthesis and antiinflammatory Properties of 2-Methylaminobenzimidazole Derivatives 180
QSAR Studies on Purine and 2,3-Dihydropurine Analogues as Antitubercular Agents 179
Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals 177
Identification of selective ligands for human fibrin recognition by means of High-Throughput Docking 177
A DFT Investigation of the Addition Reaction of Monomeric Lithium Enolate Derived from Propiophenone to Propene Oxide: Examination of the Possible Transition Structures 177
Interaction of an improved model of human A1 adenosine receptor with ligands 175
A 3D model of human A1 adenosine receptor. An evaluation of the binding free energy with ligands 173
Development of QSAR models for predicting inhibition of tubulin polymerization in the design of anticancer drugs 173
Prediction of HERG Potassium Channel Affinity by Traditional QSAR and Volsurf Approach 172
QSAR study on purine and 2,3-dihydropurine analogues as antitubercular agents 172
A search for quantum mechanical methods suitable for the conformational analysis of models related to some inverse agonists of the benzodiazepine receptor 172
Planarians as a model to assess in vivo the role of matrix metalloprotease genes during homeostasis and regeneration 172
N-(indol-3-ylglyoxilyl) amino acid Derivatives: 1H- and 13C-NMR and semiempirical quantum chemical studies 171
QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists 170
Insights into interactions between fibrin and peptidic ligands 169
Nuclear magnetic resonance structure of d(GCATATGATAG)·d(CTATCATATGC): A consensus sequence for promoters recognized by s(K) RNA polymerase 168
Effects of protoberberine and benzophenanthridine Alkaloids on human skin fibroblast proliferation 168
Introduction of a hydroxy function on N6 8-azaadenine substituents to improve the solubility and the effectiveness of antagonists towards A1 adenosine receptors 168
Planarians as a model to assess in vivo the role of matrix metalloproteinases genes during homeostasis and regeneration 166
Characterization of enzyme kinetics of human Cathepsin L 165
HIGH-THROUGHPUT DOCKING AS A TOOL FOR VIRTUAL SCREENING AND FLUORIMETRIC ASSAYS AIMED AT IDENTIFYING FIBRIN LIGANDS 164
Bioisosterism, enantioselectivity and molecular modeling of new effective N6- and/or N(9)-substituted 2-phenyl adenines and 8-aza analogs: different binding modes to A1 adenosine receptors 164
QSAR Study on Thiazole and Thiadiazole Analogues as Antagonists for the Adenosine A1 and A3 Receptors 163
Classification models for the identification of P-gp inhibitors 163
Studio conformazionale di Antagonisti del Recettore H2-histaminico 162
Enhancer and Competitive Allosteric Modulation Model for G-protein Coupled Receptors 161
Molecular Structure determination via Complete Relaxation Matrix Analysis of 2D-NOE Spectra and Molecular Mechanics: DNA fragments 158
Molecular Structure Determination via Complete Relaxation Matrix Analysis of 2D-NOE Spectra and Molecular Mechanics. Applications to DNA fragments 158
A modeling study of alphaB-crystallin in complex with zinc for investigating the correlation between chaperone-like activity and exposure of hydrophobic surfaces 158
Cytotoxic activity of polyacetylenes and polyenes isolated from E. pallida roots 157
A Novel Approach to QSPR/QSAR Based on Neural Networks for Structures 157
Ligand Design for the g(312-324) epitope of fibrin 155
Composizione comprendente un estrato di Chelidonium majus e Copaiba e il suo impiego per il trattamento di disfunzioni cutanee. 155
Understanding mechanism of selectivity between Gal- and Man-type ligands showed by human asialoglycoprotein receptor in view of predicting its interactions with exogenous sugars 154
New applications in cancer therapy: design of ligands for cathepsin L 153
Application of Cascade Correlation Networks for Structures to Chemistry 153
Computational studies of human Cathepsin L inhibition 152
A Model for Alpha1-Acid Glyciprotein and a study of its interactions with Chiral Drugs 150
Studio conformazionale della Cimetidina, Antagonista del Recettore H2-istaminergico 148
A conformational study of some 3-Methylpiperidines by low-temperature 13C-NMR spectroscopy and molecular mechanics calculations 148
La planaria come sistema modello per valutare in vivo il ruolo dei geni codificanti metalloproteasi di matrice durante l’omeostasi e la rigenerazione 148
Binding mode of Adenosine Deaminase inhibitors and zinc modeling 147
QSAR Study on Thiazole and Thiadiazole Analogues as Antagonists for the Adenosine A1 and A3 Receptors 147
A search for optimal fastness/accuracy compromises in developing predictive models for estimating CYP2D6 inhibition properties of drug candidates 147
Classification models for the identification of P-gp inhibitors. 147
Structure and Dynamics using Complete Relaxation Matrix Analysis of 2D-NOE spectra 146
Estratto di Helichrysum in olio o cera di Jojoba e composizioni a base di tale estratto, in particolare, per trattare condizioni della pelle. 146
A 3D model for the Human Hepatic Asialoglycoprotein Receptor (ASGP-R) 146
Design, Synthesis, and Biological Characterization of Bivalent Theophylline Derivatives at Adenosine A1 Receptors 145
Prediction of hERG Potassium Channel Affinity by the CODESSA Approach 145
Chemical Reactivity Predictions: Use of Data Mining Techniques for Analyzing Regioselective Azidolysis of Epoxides 144
The role of MMP-related genes as key regulators in homeostasis and regeneration of planarians 144
Understanding selectivity mechanism of human asialoglycoprotein receptor (ASGP-R) toward Gal- and Man-type ligands for predicting interactions with exogenous sugars 143
QSAR model on adenosine derivatives as antifungal agents against Candida albicans: a data mining approach 142
QSAR Model on Adenosine Derivatives as Antifungal Agents against Candida albicans: a Data Mining Approach 141
Structural Studies and Molecular Modeling of alphaB-Crystallin: Effects of Zinc and Temperature 140
Molecular Modelling of human CYP2D6 and molecular docking of a series of ajmalicine- and quinidine-like inhibitors 140
Interactions of an improved model of the the Human A1 Adenosine Receptor with Ligands 138
Theoretical Models for Classification as Cardioprotective Agents of Mitochondrial-KATP Channel Openers (mito-KCOs) Possessing the 4-Spiro-substituted Benzopyranic Structure 138
IDENTIFICATION OF "TOXICOPHORIC" FEATURES FOR PREDICTING DRUG-INDUCED QT INTERVAL PROLONGATION 138
An Attempt of modeling the Benzodiazepine Receptor: an interaction study between its Ligands and Lactate-Dehydrogenase taken as Receptor Model 137
Theoretical Studies of Interactions between Chelidocystatin and human Cathepsins for potential applications in cancer therapy 137
Computational models enabling classification of substrates for the P4503A4 isoform of human Cytochrome P450 136
Totale 17.561
Categoria #
all - tutte 57.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021228 0 0 0 0 0 0 0 0 0 0 62 166
2021/20221.528 13 132 27 76 285 185 22 65 61 38 112 512
2022/20232.533 270 332 168 261 366 355 7 164 423 7 156 24
2023/20241.749 350 201 269 102 220 296 32 33 27 21 58 140
2024/20254.640 28 182 53 295 482 442 380 252 443 594 521 968
2025/20265.106 444 790 635 335 598 463 964 206 241 417 13 0
Totale 22.780